Enlarge this image U.S. health officials approved Leqembi, a new Alzheimer’s drug that modestly slows the brain disease. The FDA granted accelerated…
FDA
-
-
News
The chase is on: Regulators are slowly cracking down on vapes aimed at teens
by Yuki Noguchi November 29, 2022Enlarge this image Nearly two years after the FDA issued a policy denouncing the marketing of fruit-flavored vape juice and other vape…
-
News
ALS drug’s approval draws cheers from patients, questions from skeptics
by Jon Hamilton September 30, 2022Enlarge this image A controversial new drug for ALS that just received FDA approval could add months to patients’ lives, but some…
-
News
FDA seems poised to approve a new drug for ALS, but does it work?
by Jon Hamilton September 21, 2022Enlarge this image The drugmaker Amylyx is asking the FDA to approve a new medication for ALS, a fatal neurodegenerative disease. It’s…
-
Enlarge this image Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food…
-
News
5 things to know about the FDA’s flawed approach to accelerated drug approvals
by Sydney Lupkin July 25, 2022Enlarge this image Kristi Alcayaga’s teenage son, Michael, was able to try a cancer drug called clofarabine that got an accelerated approval…
-
News
Drugmakers are slow to prove medicines that got a fast track to market really work
by Sydney Lupkin July 22, 2022Enlarge this image Kristi Alcayaga’s teenage son, Michael, was able to try a cancer drug called clofarabine that got an accelerated approval…
-
News
As CBD Oils Become More Popular, The FDA Considers Whether To Set New Rules
by Allison Aubrey May 31, 2019Enlarge this image Cannabidiol, or CBD, is a compound that can be extracted from marijuana or from hemp. It doesn’t get people…